Visualizing IL-18-based Immune Modulation Therapy MoA

Client:

Fuse Biotherapeutics logo

Fuse Biotherapeutics is a biotechnology company focused on developing immune-modulating therapeutics for cancer treatment, leveraging signaling molecules and multifunctional antibody domains to enhance the body’s natural immune response. Their research centers on cytokine-based therapies, particularly IL-18, which plays a critical role in immune system activation.

Fuse Biotherapeutics is a biotechnology company focused on developing immune-modulating therapeutics for cancer treatment, leveraging signaling molecules and multifunctional antibody domains to enhance the body’s natural immune response. Their research centers on cytokine-based therapies, particularly IL-18, which plays a critical role in immune system activation.

Client:

Project Goal

Project Goal

Fuse Bio required a mechanism of action (MoA) animation to effectively communicate the key advantages of their IL-18-based technology to investors and potential partners. As an early-stage company with limited resources, they needed a cost-effective yet scientifically rigorous approach to maximize impact.


To address these needs, we developed a concise 60-second animation that balanced scientific accuracy with production efficiency. The animation needed to be visually compelling, precise, and easy to understand, particularly for investors who may not have deep scientific expertise.

See full animation.

Fuse Bio required a mechanism of action (MoA) animation to effectively communicate the key advantages of their IL-18-based technology to investors and potential partners. As an early-stage company with limited resources, they needed a cost-effective yet scientifically rigorous approach to maximize impact.


To address these needs, we developed a concise 60-second animation that balanced scientific accuracy with production efficiency. The animation needed to be visually compelling, precise, and easy to understand, particularly for investors who may not have deep scientific expertise.

See full animation.

Fuse Bio required a mechanism of action (MoA) animation to effectively communicate the key advantages of their IL-18-based technology to investors and potential partners. As an early-stage company with limited resources, they needed a cost-effective yet scientifically rigorous approach to maximize impact.


To address these needs, we developed a concise 60-second animation that balanced scientific accuracy with production efficiency. The animation needed to be visually compelling, precise, and easy to understand, particularly for investors who may not have deep scientific expertise.

See full animation.

Activated T-Cell shown in orange targeting diseased cell shown in dim grey

Activated T-Cell targeting diseased cell

Activated T-Cell targeting diseased cell

Interleukin-18 and IL-18 Binding Protein

Interleukin-18 and IL-18 Binding Protein

IL-18 dused with the attenuator fragment

IL-18 and Attenuator

IL-18 and Attenuator

"Visual Science transformed our complex mechanism of action into a visually compelling story that exceeded our expectations. The attention to detail, creativity, and their ability to simplify and enhance our narrative visually was truly remarkable.

They demonstrated a deep understanding of our needs and a commitment to excellence throughout the process."

"Visual Science transformed our complex mechanism of action into a visually compelling story that exceeded our expectations. The attention to detail, creativity, and their ability to simplify and enhance our narrative visually was truly remarkable.

They demonstrated a deep understanding of our needs and a commitment to excellence throughout the process."

"Visual Science transformed our complex mechanism of action into a visually compelling story that exceeded our expectations. The attention to detail, creativity, and their ability to simplify and enhance our narrative visually was truly remarkable.

They demonstrated a deep understanding of our needs and a commitment to excellence throughout the process."

"Visual Science transformed our complex mechanism of action into a visually compelling story that exceeded our expectations. The attention to detail, creativity, and their ability to simplify and enhance our narrative visually was truly remarkable.

They demonstrated a deep understanding of our needs and a commitment to excellence throughout the process."

Patrick Hsu

Co-Founder and CEO at Fuse Biotherapeutics


Co-Founder and CEO at Fuse Biotherapeutics


L-18 binding to receptors triggering unsafe signaling

IL-18 binding to receptors triggering unsafe signaling

IL-18 binding to receptors triggering unsafe signaling

IL-18 and Fuse Bios' Attenuator approaching the IL-18 receptor

IL-18 and Fuse Bios' Attenuator

IL-18 and Fuse Bios' Attenuator

Antibody Domain bringing IL-18 to Immune Cells

Antibody Domain bringing IL-18 to Immune Cells

The Process

The Process

Animation type:

Deck 3D + High-end 3D elements

Project timline:

7 weeks

Review:

4 zoom calls + 5 e-mail feedback sessions

Find out which of our 26 scientific animation options works best for investor relations and communications:

Given the company’s early-stage status, the production process needed to be optimized for both speed and cost efficiency while maintaining the highest scientific standards. We structured the animation using a hybrid approach, selecting the most effective animation style for each scene:


DECK 3D for Introduction and Context: The opening scenes utilized DECK 3D animation, in which molecular structures remained scientifically accurate while the animation itself was less dynamic. This approach enabled faster production while keeping costs under control—key considerations for a startup operating under tight budget and timeline constraints.


Molecular Dynamics Simulation: While DECK 3D was used for parts of the animation, certain scenes required more detailed molecular interactions. These were enhanced with molecular dynamics simulations to ensure precise representation of molecular behavior and interactions.


2D Overlays for Clarity: Because the audience included investors without deep technical backgrounds, we implemented a dual-layered visualization approach. Alongside the 3D molecular animation sequences, we incorporated simplified 2D schematic overlays that mirrored key molecular processes in real time. These 2D callouts and structural highlights helped break down complex mechanisms and modifications, making them more accessible without compromising scientific accuracy.

Why did we use this
animation type?

Why did we use this
animation type?

This hybrid visual approach significantly improved the clarity of the animation, ensuring that viewers could both appreciate the molecular-level accuracy and easily follow the process. The client valued this balance, as it reinforced confidence in the scientific integrity of the animation while keeping it engaging and accessible to a broader audience. The animation was successfully delivered within six weeks, meeting the client’s tight deadlines for investor communications.

Outcome:

The final MoA animation effectively conveyed Fuse Biotherapeutics’ IL-18 technology, balancing scientific rigor with accessibility. By tailoring the animation workflow to the company’s strategic needs, the production successfully communicated the core mechanism to both technical experts and investors. The project demonstrated how flexible production choices can enhance scientific storytelling while accommodating strict timeframes and budget constraints. Fuse Biotherapeutics praised the animation for its engaging and digestible presentation, underscoring the impact of clear and compelling scientific visualization for medical & scientific communication services.

Full animation

Contact us

/10

“Fantastic team to partner with throughout the entire process. Excellent output and management!”

Pádraig Moran

Global Marketing Director, Pfizer

/10

"Visual Science produced an excellent website with incredible imagery, working in a professional, efficient manner to create a stunning final product! They were engaged through every step of the process and were attentive to the ideas we had in mind for our website. They continue to work with us on all updates and requests in a timely and helpful manner!"

Noel Kurdi

VP, Investor Relations, Apogee Therapeutics

/10

“Excellent scientific partner and first class imagery. This team runs a tight ship and the process is clear. The tech and final product are first rate.”

Bob Nichols

VP, Corp Dev, Revolution Medicines

/10

“We were impressed by the Visual Science team’s ability to use exact protein structures to depict complex mechanisms in <90 seconds. The visuals are beautiful and tell a clear story.

Rosana Kapeller

President, CEO and co-founder, ROME Therapeutics

/10

“Visual Science has a unique ability to communicate complex science with both accuracy and visual impact. Their team combines scientific understanding with creativity, helping bring sophisticated biomedical concepts to life.”

Paul Peter Tak

President, CEO and Board Director, Candel Therapeutics

/10

“We were impressed by the scientific sophistication of the Visual Science team and their skill in capturing the concepts we wanted to communicate. The final video was exceptional.”

Michael Zasloff

CSO, Enterin

/10

“I was very impressed with scientific knowledge of the Visual Science team, which led to a fantastic visualization of the MOA of our drug. Attention to scientific details was extraordinary.”

Guru Reddy

Vice President, R&D, Unicycive Therapeutics

/10

"Visual Science was a great partner in the development and delivery of scientific animations; the combination of their understanding of the science and their artistic expertise resulted in a visually stunning and impactful video."

Lynnea Waters

Director, Scientific Communications, Apogee Therapeutics

/10

“Visual Science is a fantastic partner, capable of rendering the most complex science in compelling ways. They understood the science, and their production was excellent.”

Ravi Moorthy

VP, Head of Communications, Scorpion Therapeutics

/10

“Visual Science team has just the right blend of scientific acumen and digital animation expertise to pull off these challenging projects.”

John Hanna

CEO, Apton

/10

“We are very pleased with Visual Science — they are a very responsive group to work with and the final product is exactly what we had envisioned.”

Patrick Ritschel

CEO, Atsena Therapeutics

/10

“The scientific expertise really showed in the discussions and final products. Everybody was responsive and great to work with, and the animations were both engaging and accurate!”

Blake Aronson

Program Manager, ACS

/10

“The creativity, scientific competency and professionalism of the Visual Science team not only enabled the generation of high-quality images, but also made it a pleasure to work with them.”

Jan Smith

CSO, Biology, Revolution Medicines

/10

"Incredible animations that really help bring our science to life. I strongly recommend Visual Science!"

Josh Cirulli

VP, Medical Affairs, Apogee Therapeutics

/10

“The quality of the work from Visual Science was outstanding. They provide a bespoke service that was responsive to our requests and I would recommend them highly.”

Anirvan Ghosh

CEO, UNITY Biotechnology

/10

"We were impressed with the Visual Science team's attention to detail and ability to extract key messages out of a complex scientific story. Their deep understanding of the science enabled them to turn our cryo-EM structures into a beautiful visual that shows the key aspects of the bridge recombination mechanism."

Patrick Hsu

Co-Founder, Arc Institute · Assistant Professor, UC Berkeley

/10

"The Visual Science team did an outstanding job delivering beautiful MOA videos for us. The animations and attention to detail were exceptional, and their flexibility throughout the process made a huge difference."

Jen Do, Associate Director, External Sci Comm, AbbVie

Jen Do

Associate Director, External Sci Comm, AbbVie

/10

"Excellent work by the Visual Science team!"

Miguel Sobral

Associate Director, BD&Strategy, Apogee Therapeutics

/10

"Excellent work and project management."

Daniel Martins, Scientific Director, AbbVie

Daniel Martins

Scientific Director, AbbVie

/10

"Visual Science produces high quality animations to support our unique science with agility and speed. I do value their partnership and look forward to working on more projects with them."

Aparna Shetty, Lead, Scientific Communications and Content, Astellas

Aparna Shetty

Lead, Scientific Communications and Content, Astellas

/10

"The VS team was outstanding to work with on this project. From the outset, the level of communication, organization, and attention to detail was exceptional. The VS team moved a complication MoA project forward on-schedule, with scientific rigor, and the result was a beautifully composed video that distilled complex biology in a visually accurate way. I highly recommend this team."

Taylor Schreiber, CEO, Shattuck Labs, Inc.

Taylor Schreiber

CEO, Shattuck Labs, Inc.

/10

"Thank you very much for such a great deliverable on a very tight timeline. I have been doing things like this for a long time and your incorporation of the Atsena insights to this with a very fast turnaround is very much appreciated and impressive."

Edmund Doherty - Vice President of Medical Affairs | Clinical Strategy | Global People Leader, Atsena Therapeutics

Edmund Doherty

Vice President of Medical Affairs, Atsena Therapeutics

/10

"Very responsive and efficient. Thank you!"

Brian Padden, Asset Strategy Leader, AbbVie

Brian Padden

Asset Strategy Leader, AbbVie

Contact us

/10

“Fantastic team to partner with throughout the entire process. Excellent output and management!”

Pádraig Moran

Global Marketing Director, Pfizer

/10

"Visual Science produced an excellent website with incredible imagery, working in a professional, efficient manner to create a stunning final product! They were engaged through every step of the process and were attentive to the ideas we had in mind for our website. They continue to work with us on all updates and requests in a timely and helpful manner!"

Noel Kurdi

VP, Investor Relations, Apogee Therapeutics

/10

“Excellent scientific partner and first class imagery. This team runs a tight ship and the process is clear. The tech and final product are first rate.”

Bob Nichols

VP, Corp Dev, Revolution Medicines

/10

“We were impressed by the Visual Science team’s ability to use exact protein structures to depict complex mechanisms in <90 seconds. The visuals are beautiful and tell a clear story.

Rosana Kapeller

President, CEO and co-founder, ROME Therapeutics

/10

“Visual Science has a unique ability to communicate complex science with both accuracy and visual impact. Their team combines scientific understanding with creativity, helping bring sophisticated biomedical concepts to life.”

Paul Peter Tak

President, CEO and Board Director, Candel Therapeutics

/10

“We were impressed by the scientific sophistication of the Visual Science team and their skill in capturing the concepts we wanted to communicate. The final video was exceptional.”

Michael Zasloff

CSO, Enterin

/10

“I was very impressed with scientific knowledge of the Visual Science team, which led to a fantastic visualization of the MOA of our drug. Attention to scientific details was extraordinary.”

Guru Reddy

Vice President, R&D, Unicycive Therapeutics

/10

"Visual Science was a great partner in the development and delivery of scientific animations; the combination of their understanding of the science and their artistic expertise resulted in a visually stunning and impactful video."

Lynnea Waters

Director, Scientific Communications, Apogee Therapeutics

/10

“Visual Science is a fantastic partner, capable of rendering the most complex science in compelling ways. They understood the science, and their production was excellent.”

Ravi Moorthy

VP, Head of Communications, Scorpion Therapeutics

/10

“Visual Science team has just the right blend of scientific acumen and digital animation expertise to pull off these challenging projects.”

John Hanna

CEO, Apton

/10

“We are very pleased with Visual Science — they are a very responsive group to work with and the final product is exactly what we had envisioned.”

Patrick Ritschel

CEO, Atsena Therapeutics

/10

“The scientific expertise really showed in the discussions and final products. Everybody was responsive and great to work with, and the animations were both engaging and accurate!”

Blake Aronson

Program Manager, ACS

/10

“The creativity, scientific competency and professionalism of the Visual Science team not only enabled the generation of high-quality images, but also made it a pleasure to work with them.”

Jan Smith

CSO, Biology, Revolution Medicines

/10

"Incredible animations that really help bring our science to life. I strongly recommend Visual Science!"

Josh Cirulli

VP, Medical Affairs, Apogee Therapeutics

/10

“The quality of the work from Visual Science was outstanding. They provide a bespoke service that was responsive to our requests and I would recommend them highly.”

Anirvan Ghosh

CEO, UNITY Biotechnology

/10

"We were impressed with the Visual Science team's attention to detail and ability to extract key messages out of a complex scientific story. Their deep understanding of the science enabled them to turn our cryo-EM structures into a beautiful visual that shows the key aspects of the bridge recombination mechanism."

Patrick Hsu

Co-Founder, Arc Institute · Assistant Professor, UC Berkeley

/10

"The Visual Science team did an outstanding job delivering beautiful MOA videos for us. The animations and attention to detail were exceptional, and their flexibility throughout the process made a huge difference."

Jen Do, Associate Director, External Sci Comm, AbbVie

Jen Do

Associate Director, External Sci Comm, AbbVie

/10

"Excellent work by the Visual Science team!"

Miguel Sobral

Associate Director, BD&Strategy, Apogee Therapeutics

/10

"Excellent work and project management."

Daniel Martins, Scientific Director, AbbVie

Daniel Martins

Scientific Director, AbbVie

/10

"Visual Science produces high quality animations to support our unique science with agility and speed. I do value their partnership and look forward to working on more projects with them."

Aparna Shetty, Lead, Scientific Communications and Content, Astellas

Aparna Shetty

Lead, Scientific Communications and Content, Astellas

/10

"The VS team was outstanding to work with on this project. From the outset, the level of communication, organization, and attention to detail was exceptional. The VS team moved a complication MoA project forward on-schedule, with scientific rigor, and the result was a beautifully composed video that distilled complex biology in a visually accurate way. I highly recommend this team."

Taylor Schreiber, CEO, Shattuck Labs, Inc.

Taylor Schreiber

CEO, Shattuck Labs, Inc.

/10

"Thank you very much for such a great deliverable on a very tight timeline. I have been doing things like this for a long time and your incorporation of the Atsena insights to this with a very fast turnaround is very much appreciated and impressive."

Edmund Doherty - Vice President of Medical Affairs | Clinical Strategy | Global People Leader, Atsena Therapeutics

Edmund Doherty

Vice President of Medical Affairs, Atsena Therapeutics

/10

"Very responsive and efficient. Thank you!"

Brian Padden, Asset Strategy Leader, AbbVie

Brian Padden

Asset Strategy Leader, AbbVie

Contact us

Contact us

Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.

We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.

Contacts

US toll-free

1 888 374-16-95

NY

1 516 340-37-30

Address

200 Vesey Street, 24th floor,
New York, NY 10281, USA

Social networks

LinkedIn Logo
Vimeo Logo

© 2026, Visual Science. All rights reserved.

Privacy policy & Cookie policy

  • The Telly Awards logo
  • Hermes Creative Awards Logo
  • The Communicator Awards logo
  • National Science Foundation logo
  • Science Magazine Logo
  • Viddy Awards Logo

Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.

We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.

Contacts

US toll-free

1 888 374-16-95

NY

1 516 340-37-30

Address

200 Vesey Street, 24th floor,
New York, NY 10281, USA

Social networks

LinkedIn Logo
Vimeo Logo

© 2026, Visual Science. All rights reserved.

Privacy policy & Cookie policy

  • The Telly Awards logo
  • Hermes Creative Awards Logo
  • The Communicator Awards logo
  • National Science Foundation logo
  • Science Magazine Logo
  • Viddy Awards Logo

Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.

We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.

Contacts

US toll-free

1 888 374-16-95

NY

1 516 340-37-30

Address

200 Vesey Street, 24th floor, New York, NY 10281, USA

© 2026, Visual Science. All rights reserved.

Privacy policy & Cookie policy

  • The Telly Awards logo
  • Hermes Creative Awards Logo
  • The Communicator Awards logo
  • National Science Foundation logo
  • Science Magazine Logo
  • Viddy Awards Logo

Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.

We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.

Contacts

US toll-free

1 888 374-16-95

NY

1 516 340-37-30

Address

200 Vesey Street, 24th floor,
New York, NY 10281, USA

Social networks

LinkedIn Logo
Vimeo Logo

© 2026, Visual Science. All rights reserved.

Privacy policy & Cookie policy

  • The Telly Awards logo
  • Hermes Creative Awards Logo
  • The Communicator Awards logo
  • National Science Foundation logo
  • Science Magazine Logo
  • Viddy Awards Logo
Visual Science Logo